Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1964 1
1966 3
1967 1
1968 2
1970 1
1971 3
1972 3
1973 1
1974 4
1975 3
1976 4
1977 4
1978 2
1979 3
1980 1
1981 6
1982 4
1983 2
1984 2
1985 4
1986 5
1987 5
1988 4
1989 6
1990 5
1991 9
1992 9
1993 10
1994 6
1995 13
1996 6
1997 13
1998 7
1999 13
2000 19
2001 15
2002 18
2003 17
2004 25
2005 30
2006 28
2007 25
2008 16
2009 19
2010 17
2011 29
2012 25
2013 27
2014 25
2015 27
2016 35
2017 43
2018 58
2019 63
2020 80
2021 58
2022 38
2023 45
2024 23

Text availability

Article attribute

Article type

Publication date

Search Results

850 results

Results by year

Filters applied: . Clear all
Page 1
Evidence-Based Clinical Practice Guidelines for Extramammary Paget Disease.
Kibbi N, Owen JL, Worley B, Wang JX, Harikumar V, Downing MB, Aasi SZ, Aung PP, Barker CA, Bolotin D, Bordeaux JS, Cartee TV, Chandra S, Cho NL, Choi JN, Chung KY, Cliby WA, Dorigo O, Eisen DB, Fujisawa Y, Golda N, Halfdanarson TR, Iavazzo C, Jiang SIB, Kanitakis J, Khan A, Kim JYS, Kuzel TM, Lawrence N, Leitao MM Jr, MacLean AB, Maher IA, Mittal BB, Nehal KS, Ozog DM, Pettaway CA, Ross JS, Rossi AM, Servaes S, Solomon MJ, Thomas VD, Tolia M, Voelzke BB, Waldman A, Wong MK, Zhou Y, Arai N, Brackett A, Ibrahim SA, Kang BY, Poon E, Alam M. Kibbi N, et al. Among authors: fujisawa y. JAMA Oncol. 2022 Apr 1;8(4):618-628. doi: 10.1001/jamaoncol.2021.7148. JAMA Oncol. 2022. PMID: 35050310
Reply.
Hirata A, Ogura T, Hayashi N, Takenaka S, Ito H, Mizushina K, Fujisawa Y, Yamashita N, Nakahashi S, Imamura M, Kujime R, Kameda H. Hirata A, et al. Among authors: fujisawa y. Arthritis Care Res (Hoboken). 2018 Jul;70(7):1119. doi: 10.1002/acr.23344. Epub 2018 Apr 26. Arthritis Care Res (Hoboken). 2018. PMID: 28834302 No abstract available.
Response to RMED-D-22-00,258.R1.
Ohno Y, Aoyagi K, Arakita K, Doi Y, Kondo M, Banno S, Kasahara K, Ogawa T, Kato H, Hase R, Kashizaki F, Nishi K, Kamio T, Mitamura K, Ikeda N, Nakagawa A, Fujisawa Y, Taniguchi A, Ikeda H, Hattori H, Murayama K, Toyama H. Ohno Y, et al. Among authors: fujisawa y. Jpn J Radiol. 2022 Aug;40(8):860-861. doi: 10.1007/s11604-022-01308-8. Epub 2022 Jun 25. Jpn J Radiol. 2022. PMID: 35751793 Free PMC article. No abstract available.
IGF2 Mutations.
Masunaga Y, Inoue T, Yamoto K, Fujisawa Y, Sato Y, Kawashima-Sonoyama Y, Morisada N, Iijima K, Ohata Y, Namba N, Suzumura H, Kuribayashi R, Yamaguchi Y, Yoshihashi H, Fukami M, Saitsu H, Kagami M, Ogata T. Masunaga Y, et al. Among authors: fujisawa y. J Clin Endocrinol Metab. 2020 Jan 1;105(1):dgz034. doi: 10.1210/clinem/dgz034. J Clin Endocrinol Metab. 2020. PMID: 31544945 Review.
BCOR-CCNB3 Fusion Positive Sarcomas: A Clinicopathologic and Molecular Analysis of 36 Cases With Comparison to Morphologic Spectrum and Clinical Behavior of Other Round Cell Sarcomas.
Kao YC, Owosho AA, Sung YS, Zhang L, Fujisawa Y, Lee JC, Wexler L, Argani P, Swanson D, Dickson BC, Fletcher CDM, Antonescu CR. Kao YC, et al. Among authors: fujisawa y. Am J Surg Pathol. 2018 May;42(5):604-615. doi: 10.1097/PAS.0000000000000965. Am J Surg Pathol. 2018. PMID: 29300189 Free PMC article.
Authors' reply.
Kountikov E, Fujisawa Y, Tedder TF. Kountikov E, et al. Among authors: fujisawa y. Am J Pathol. 2015 Nov;185(11):3127-8. doi: 10.1016/j.ajpath.2015.09.002. Am J Pathol. 2015. PMID: 26506475 Free article. No abstract available.
Eribulin mesylate exerts antitumor effects via CD103.
Oya K, Nakamura Y, Watanabe R, Tanaka R, Ichimura Y, Kubota N, Matsumura Y, Tahara H, Okiyama N, Fujimoto M, Nomura T, Fujisawa Y. Oya K, et al. Among authors: fujisawa y. Oncoimmunology. 2023 May 27;12(1):2218782. doi: 10.1080/2162402X.2023.2218782. eCollection 2023. Oncoimmunology. 2023. PMID: 37261089 Free PMC article.
Loricrin Protects against Chemical Carcinogenesis.
Ogawa T, Ishitsuka Y, Nakamura Y, Watanabe R, Okiyama N, Fujisawa Y, Fujimoto M, Roop DR, Nomura T. Ogawa T, et al. Among authors: fujisawa y. J Invest Dermatol. 2022 Jul;142(7):2023-2026.e1. doi: 10.1016/j.jid.2021.12.015. Epub 2021 Dec 27. J Invest Dermatol. 2022. PMID: 34968502 Free article. No abstract available.
Tumor-Associated Macrophages: Therapeutic Targets for Skin Cancer.
Fujimura T, Kambayashi Y, Fujisawa Y, Hidaka T, Aiba S. Fujimura T, et al. Among authors: fujisawa y. Front Oncol. 2018 Jan 23;8:3. doi: 10.3389/fonc.2018.00003. eCollection 2018. Front Oncol. 2018. PMID: 29410946 Free PMC article. Review.
Loricrin and NRF2 Coordinate Cornification.
Ishitsuka Y, Ogawa T, Nakamura Y, Kubota N, Fujisawa Y, Watanabe R, Okiyama N, Fujimoto M, Roop DR, Ishida-Yamamoto A. Ishitsuka Y, et al. Among authors: fujisawa y. JID Innov. 2021 Oct 15;2(1):100065. doi: 10.1016/j.xjidi.2021.100065. eCollection 2022 Jan. JID Innov. 2021. PMID: 35024686 Free PMC article.
850 results